pcDNA3 c-SRC (151-536) Citations (1)

Originally described in: beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ J Biol Chem. 2000 Apr 14;275(15):11312-9. PubMed Journal

---

Articles Citing pcDNA3 c-SRC (151-536)

Articles
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Iida M, Sahashi K, Kondo N, Nakatsuji H, Tohnai G, Tsutsumi Y, Noda S, Murakami A, Onodera K, Okada Y, Nakatochi M, Tsukagoshi Okabe Y, Shimizu S, Mizuno M, Adachi H, Okano H, Sobue G, Katsuno M. Nat Commun. 2019 Sep 19;10(1):4262. doi: 10.1038/s41467-019-12282-7. PubMed

If you have published an article using this material, please email us at to have your article added to this page.